Video Experimental Relacionado
Updated: Sep 10, 2025
11:00
Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes
Published on: September 18, 2017
10.2K
TRPM7 cardíaco causa insuficiencia cardíaca diabética con fracción de eyección preservada
Man Liu1, Hong Liu1, Gyeoung-Jin Kang1
1Cardiovascular Division, Department of Medicine, Lillehei Heart Institute, University of Minnesota-Twin Cities, Minneapolis, Minnesota, USA.
JACC. Basic to translational science
|August 27, 2025
Resumen
La hipomagnesemia causa insuficiencia cardíaca diabética. La inhibición de la cinasa TRPM7, regulada al alza en esta condición, puede tratar la insuficiencia cardíaca con fracción de eyección preservada al reducir el estrés oxidativo y la disfunción mitocondrial.
Área de la Ciencia:
- La bioquímica
- Cardiología
- Biología molecular
Sus antecedentes:
- La hipomagnesemia y el estrés oxidativo contribuyen a la disfunción diastólica cardíaca diabética y a la insuficiencia cardíaca con fracción de eyección preservada.
- La subfamilia de canales cationales del receptor potencial transitorio M7 (TRPM7), un transportador de magnesio, está regulada al alza en la hipomagnesemia.
Objetivo del estudio:
- Investigar el papel de TRPM7 en la insuficiencia cardíaca diabética con fracción de eyección preservada.
- Para explorar la cinasa TRPM7 como objetivo terapéutico.
Principales métodos:
- Utilizó un modelo de ratón de la diabetes mellitus.
- Se evaluó la expresión y actividad de TRPM7 en el tejido cardíaco.
- Se examinó el impacto de la cinasa TRPM7 en la función mitocondrial y el estrés oxidativo.
Principales resultados:
- Los ratones diabéticos presentaron hipomagnesemia y un aumento de la expresión cardíaca de TRPM7.
- La actividad de la cinasa TRPM7 se relacionó con la disfunción mitocondrial y la disfunción diastólica cardíaca.
- La cinasa TRPM7 aumentó la regulación de la Fgr mitocondrial, lo que condujo a una disfunción del complejo II y a una sobreproducción de especies reactivas de oxígeno.
Conclusiones:
- La cinasa TRPM7 juega un papel crítico en la patogénesis de la insuficiencia cardíaca diabética con fracción de eyección preservada.
- La inhibición de la cinasa TRPM7 es una estrategia terapéutica potencial para esta condición.
Videos de Conceptos Relacionados
01:30Cardiomyopathy II: Dilated Cardiomyopathy
21
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
21
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
27
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
27
01:27Heart Failure I: Introduction
52
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
52
01:17Pathophysiology of Heart Failure
1.8K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.8K
01:25Cardiomyopathy I: Introduction and Classification
50
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
50
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
45
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
45